1057.1000 26.95 (2.62%)
NSE Nov 16, 2026 15:31 PM
Volume: 452.1K
 

BOB Capital Markets Ltd.
US and ROW sales grew above our estimates of 5% and 13% respectively, reporting growth of 10% each
Alembic Pharma has gained 27.17% in the last 3 Months
More from Alembic Pharmaceuticals Ltd.
Recommended